These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 18544428)
21. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care. Teitel JM; Carcao M; Lillicrap D; Mulder K; Rivard GE; St-Louis J; Smith F; Walker I; Zourikian N Haemophilia; 2009 Jan; 15(1):227-39. PubMed ID: 18752535 [TBL] [Abstract][Full Text] [Related]
22. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors. Hough RE; Hampton KK; Preston FE; Channer KS; West J; Makris M Br J Haematol; 2000 Dec; 111(3):974-9. PubMed ID: 11122162 [TBL] [Abstract][Full Text] [Related]
23. Monitoring inhibitor patients with the right assays. Barrowcliffe TW Semin Hematol; 2008 Apr; 45(2 Suppl 1):S25-30. PubMed ID: 18544420 [TBL] [Abstract][Full Text] [Related]
24. Bypassing agent prophylaxis for preventing arthropathy in patients with inhibitors. Ewenstein BM; Wong WY; Schoppmann A Haemophilia; 2010 Jan; 16(1):179-80. PubMed ID: 19702885 [No Abstract] [Full Text] [Related]
25. Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience. Habermann B; Hochmuth K; Hovy L; Scharrer I; Kurth AH Haemophilia; 2004 Nov; 10(6):705-12. PubMed ID: 15569165 [TBL] [Abstract][Full Text] [Related]
26. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors. Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575 [TBL] [Abstract][Full Text] [Related]
27. A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision. Leblebisatan G; Sasmaz I; Antmen B; Kilinc Y; Sizmaz S; Yagmur M Haemophilia; 2006 Mar; 12(2):187-9. PubMed ID: 16476096 [No Abstract] [Full Text] [Related]
28. Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor. O'Marcaigh AS; Schmalz BJ; Shaughnessy WJ; Gilchrist GS Mayo Clin Proc; 1994 Jul; 69(7):641-4. PubMed ID: 8015327 [TBL] [Abstract][Full Text] [Related]
30. Orthopaedic surgery in haemophilia patients with inhibitors as the last resort. Rodriguez-Merchan EC; Quintana M; Jimenez-Yuste V Haemophilia; 2008 Nov; 14 Suppl 6():56-67. PubMed ID: 19134035 [TBL] [Abstract][Full Text] [Related]
31. [Rehabilitation in haemophilic children with inhibitors using recombinant activated factor VII]. Janić D; Petronić I; Dokmanović L; Krstovski N; Lazić J; Rodić P Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():226-30. PubMed ID: 19562874 [TBL] [Abstract][Full Text] [Related]
32. Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial. Pruthi RK; Mathew P; Valentino LA; Sumner MJ; Seremetis S; Hoots WK; Thromb Haemost; 2007 Oct; 98(4):726-32. PubMed ID: 17938794 [TBL] [Abstract][Full Text] [Related]
33. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor. Laguna P; Klukowska A Haemophilia; 2005 Jan; 11(1):2-4. PubMed ID: 15660981 [TBL] [Abstract][Full Text] [Related]
34. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352 [TBL] [Abstract][Full Text] [Related]
35. The use of activated factor VII for ventricular septal defect closure in a pediatric patient with hemophilia A and a high titer of inhibitor. de Souza DG; Waldron PE; Peeler BB; Baum VC J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):679-81. PubMed ID: 19054692 [No Abstract] [Full Text] [Related]
36. Risks and patient outcomes of surgical intervention for hemophilic arthropathy. Rodriguez-Merchan EC Expert Rev Hematol; 2019 May; 12(5):325-333. PubMed ID: 30929534 [TBL] [Abstract][Full Text] [Related]
37. Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: evaluation of the efficacy of recombinant factor VIIa in the evolution process (EFFISEVEN protocol). Querol F; Cortina V; Cid AR; Haya S; Aznar JA Haemophilia; 2008 Nov; 14 Suppl 6():36-44. PubMed ID: 19134032 [TBL] [Abstract][Full Text] [Related]
38. Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres. Escobar M; Maahs J; Hellman E; Donkin J; Forsyth A; Hroma N; Young G; Valentino LA; Tachdjian R; Cooper DL; Shapiro AD Haemophilia; 2012 Nov; 18(6):971-81. PubMed ID: 22776076 [TBL] [Abstract][Full Text] [Related]
39. New house or new limbs?! Nwachuku I; Obi N; Housden P; Winter M Ann R Coll Surg Engl; 2010 Jul; 92(5):W7-9. PubMed ID: 20529452 [TBL] [Abstract][Full Text] [Related]
40. Use of FEIBA for invasive or surgical procedures in patients with severe hemophilia A or B with inhibitors. Stine KC; Shrum D; Becton DL J Pediatr Hematol Oncol; 2007 Apr; 29(4):216-21. PubMed ID: 17414562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]